Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish High- and Low-Risk Patients with TNBC By Ogkologos - May 5, 2026 76 0 Facebook Twitter Google+ Pinterest WhatsApp Building the PREDICT_sTILs prognostication model Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Two Separate Indications for fam-Trastuzumab Deruxtecan-nxki in HER2-Positive Early-Stage Breast Cancer ESMO Calls for Further EU Measures Enhancing Europe’s Clinical Trial Regulatory Ecosystem Following Meeting of Health Ministers on 16 June 2026 ESMO Responds to Public Consultation on EU4Health Work Programme for 2027 and Highlights the Importance of Continuing Robust EU Support for Europe’s Beating Cancer... MOST POPULAR Adding Atezolizumab to Chemotherapy Does Not Improve Outcomes in Patients Who... June 4, 2024 Grieving for Your Old Life After Cancer September 10, 2020 A Nurse’s Love For Oncology Patients May 20, 2021 Pesticide Usage, in Particular of Picloram, Associated with Early Onset Colorectal... May 4, 2026 Load more HOT NEWS Educators Raise Money in Memory of Teacher Who Dedicated Herself to... Introducing our new podcast for researchers Could Cholesterol-Lowering Drugs Improve Cancer Immunotherapy? First-Line Treatment with Atezolizumab Associated with Improved OS in Patients with...
